<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/WebSite>
<http://www.genengnews.com/keywordsandtools/email/gen-news-highlights/allergan-licenses-molecular-partners-phase-ii-eye-disease-protein-therapeutic-for-45m/22960/>